Artificial intelligence support for liver surgery decisions
Part of Cancer, Digestive system clinical trials.
This study uses artificial intelligence on your CT scan to help doctors make better decisions before and after liver surgery. It aims to improve safety and outcomes for people having surgery for liver cancer or other liver conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have liver cancer, a liver mass, or cirrhosis (liver scarring) and are planning to have liver surgery.
- You are willing to take part and sign a consent form.
- You are not pregnant.
- Your kidney function is adequate (GFR greater than 60).
- You have no history of allergy to contrast dye used in CT scans.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses artificial intelligence to look at CT scans you've already had (without dye) to try and find signs of several types of cancer early. It may help find cancer sooner when it's easier to treat.
This trial uses an AI system to help doctors plan surgery for liver cancer. It is for people who have had a CT scan of their liver and may or may not have a liver tumor.
This trial is testing a computer program that can automatically analyze medical images like CT scans from people who have had laparoscopic liver, gallbladder, or pancreas surgery. The goal is to see if the AI can help doctors better plan and perform these surgeries.
This study uses digital scans of your tumor tissue and CT/MRI images to build a computer model that helps predict whether you might need extra treatment (adjuvant therapy) after liver cancer surgery. The goal is to use your own tissue and scan data to personalize follow-up care.
This study uses a computer program to help doctors look for cancer in the liver on CT scans. It aims to see if the AI tool makes reading scans faster and more accurate, which could help catch issues sooner.
This trial uses artificial intelligence to help doctors better stage (classify the severity of) and plan treatment for hepatocellular carcinoma, a type of primary liver cancer. Researchers will collect your clinical information and imaging to see if AI can improve decision-making about your care.
Hear when a new Liver Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.